The silencing of TFEB also changed the susceptibility to apoptosis of cancer cells and the tumor immune micro-environment (TIME) qualitative and quantitative composition, as indicated by the scRNA-Seq analysis of the immuno-xenografts. The gene discussed is TFEB; the disease is neoplasm.